Hepatitis B: epidemiological, immunological, and serological considerations emphasizing mutation

Area of Science:

• Hepatology
• Virology
• Infectious Diseases

Background:

• Global prevalence of Hepatitis B virus (HBV) affects 350 million chronic carriers, with significant regional variations.
• HBV exhibits 7 genotypes (A-G) and 4 subtypes (adw, ayw, adr, ayr), influencing geographic distribution and prognosis.
• Standard serologic tests may fail to detect mutant HBV strains, a growing concern due to antiviral resistance and vaccine escape.

Purpose of the Study:

• To highlight the diagnostic challenges posed by mutant Hepatitis B virus.
• To emphasize the importance of considering HBV mutations in clinical practice.

Main Methods:

• Review of current literature on HBV genotypes, subtypes, and mutations.
• Analysis of diagnostic limitations of standard serologic tests for HBV.
• Discussion of clinical scenarios indicative of occult hepatitis B.

Main Results:

• Mutations in HBV surface, polymerase, X, core, and precore genes are described.
• Mutations in surface and core/precore genes can lead to "occult hepatitis," where key serologic markers are negative.
• Increased prevalence of mutant HBV is linked to antiviral therapy, immunosuppression, and vaccine escape.

Conclusions:

• Mutant Hepatitis B virus presents diagnostic difficulties, often evading standard serologic detection.
• Occult hepatitis B, characterized by negative HBsAg and HBeAg, requires high clinical suspicion.
• Suspect HBV mutation in cases of unexplained worsening clinical status despite seemingly controlled infection markers.